Going the distance: Conformable Gore TAG device demonstrates durable outcomes over the long. D.Böckler University Hospital Heidelberg, Germany
|
|
|
- Magdalen Stafford
- 5 years ago
- Views:
Transcription
1 Going the distance: Conformable Gore TAG device demonstrates durable outcomes over the long D.Böckler University Hospital Heidelberg, Germany
2 Disclosures Speaker name: Dittmar Böckler I have the following potential conflicts of interest to report: Consulting Employment in industry Stockholder of a healthcare company Owner of a healthcare company Research Grant I do not have any potential conflict of interest
3 Launch: October Implants worldwide
4 Concept of CTAG FDA-approved to treat various thoracic aortic pathologies
5 Concept: Device Modifications Design Size - Configurations
6 Concept - Oversizing windows for different pathologies Aortic diameter 31mm: TAG 34 mm Aortic diameter 31mm: CTAG 34 / 37 / 40mm CTAG - engineered for 6-33% oversizing conditions IMH with 31 mm > CTAG 34 mm = 10 % Oversizing TAA with 31 mm > CTAG 37 mm = 20 % Ovversizing
7 4-5 Years Results with CTAG (mean 2 yrs.) Prospective Multicentre Regulatory US- Study 1 Prospective Multicentre Europen Registry 2 GREAT Registry unpublished Single Center Experience 2 Heidelberg Experience (407 devices/163 pat.) unpublished HUMAN STUDY eissn Med Sci Monit Basic Res, 2015; 21: DOI: /MSMBR Received: Accepted: Published: Device Conformabilit y and Morphological Assessment Af t er TEVAR for Aortic Type B Dissect ion: A Single-Cent re Experience with a Conformable Thoracic Stent-Graf t Design Authors Contribution: Study Design A Data Collection B Statistical Analysis C Data Interpretation D Manuscript Preparation E Literature Search F Funds Collection G ABCDEF 1 BCD 2 BEF 1 EF 1 ACDE 1 Corresponding Author: Source of support: Background: Material/Methods: Results: 1Jordan Moritz S. Bischoff Matthias Müller-Eschner Katrin Meisenbacher Andreas S. Peters Dittmar Böckler 1 Department of Vascular and Endovascular Surgery, Heidelberg University Hospital, Heidelberg, Germany 2 Department of Radiodiagnostics and Interventional Radiology, Heidelberg University Hospital, Heidelberg, Germany Dittmar Böckler, dittmar.boeckler@med.uni-heidelberg.de Departmental sources The aim of this study was to analyze device conformability in TEVARof acute and chronic (a/c) type B aortic dissections (TBAD) using the Gore Conformab le Thoracic Aortic Stent-graft (CTAG). From January 1997 to February 2014, a total of 90 out of 405 patients in our center received TEVARfor TBAD. Since November 2009, 23 patients (16 men; median age: 62 years) were treated with the CTAG. Indications were complicated atbad in 15 (65%) and expanding ctbad in 8 (35%) patients. Primary endpoints were the assessment of device conformability by measuring the distance (D) from the radiopaque gold band marker (GM) at the proximal CTAG end to the inner curvature (IC) of the arch on parasagittal multiplanar reformations of CT angiography, as well as the evaluation of aortic diameter changes following TEVAR. Median follow-up was 13.3 months (range: 2 days to 35 months). Primary and secondary success rates were 91.3%(21/23) and 95.6%(22/23), respectively. There was 1 type Ia endoleak, retrograde dissection or primary conversion was not observed. Median GM-IC-D was 0 mm (range: 0 mm to 10 mm). GM-IC-Dwas associated with zone 2 placement compared to zone 3 (P=0.036). There was no association between GM-IC-D formation and arch type. In atbad cases the true lumen significantly increased after TEVAR(P=0.017) and the false lumen underwent shrinkage (P=0.025). In ctbad patients the false lumen decreased after TEVAR(P=0.036). The CTAGshows favorable conformability and wall apposition in challenging arch pathologies such as TBAD., JVS 2015, 2Böckler EJVES 2016, 3 Bischoff Med Sci Research 2015, 3Böckler,Endovascular Today 2014 Conclusions: MeSH Keywords: Aneurysm, Dissecting Cardiovascular Diseases Endovascular Procedures
8 CTAG Aneurysm Study (USA) 1 Jordan W et al., JVS 2015:61: sites: 66 patients all aneurysms (DTAA) Oct Sept d results: Mortality 1.5 % Any SAE 23 % Paraplegia 2 % Stroke 2 % 2 yrs. results Type Ia Endoleak 3.2 % TAA rupture 0 % 5 mm decrease 86%
9 Aneurysm Related Survival: 97% (n=2) 1 rupture of ascending aneurysm 1 arterial access rupture for secondary intervention both separate from procedure 1 Jordan W et al., JVS 2015:61:589-95
10 European Prospective CTAG Registry 5 sites: 100 patients 56 TAA, 32 B-Diss., 4 Trauma 30 day Results Technical success 92 % Mortality 3.3% Complication rate 34 % Stroke rate 11% 2 yr. Results Overall survival 74% - Elective 80% - Emergency 62% Böckler, Brunkwall, Taylor, Mangilardi, Larzon EJVES. 2016;51:
11 Technical Results Device deployment 100 % Accuracy deployment 99 % Conformability 95 % Böckler, Brunkwall, Taylor, Mangilardi, Larzon EJVES. 2016;51:
12 Predicting Risk Factors for Death and SAE Böckler, Brunkwall, Taylor, Mangilardi, Larzon EJVES. 2016;51:
13 GREAT - Real World Registry
14 GREAT - Real World Registry
15 GREAT - Real World Registry (n=133 through 2 years follow up) 2 Type Ia endoleaks 4 Type Ib endoleaks 2 type II endoleaks 1 migration 3% device related re-intervention through 2 yr. FU 8% death rate though 2 year follow up
16 Device Conformability HUMAN STUDY eissn Med Sci Monit Basic Res, 2015; 21: DOI: /MSMBR Device Conformability and Morphological Assessment After TEVAR for Aortic Type B Dissection: A Single-Centre Experience with a Conformable Thoracic Stent-Graft Design n: A B C D E F G ABCDEF 1 BCD 2 BEF 1 EF 1 ACDE 1 nding Author: Moritz S. Bischoff Matthias Müller-Eschner Katrin Meisenbacher Andreas S. Peters Dittmar Böckler Dittmar Böckler, dittmar.boeckler@med.uni-heidelberg.de 1 Department of Vascular and Endovascular Surgery, Heidelberg University Hospital, Heidelberg, Germany 2 Department of Radiodiagnostics and Interventional Radiology, Heidelberg University Hospital, Heidelberg, Germany Apposition to inner wall 100% N = 1 (5,0%) N = 13 (65,0%) N = 6 (30,0%) No association between apposition and arch type 21/23) and 95.6% (22/23), respectively. There was 1 type Ia endoleak, retrograde dissection or primary conversion was not observed. Median GM-IC-D was 0 mm (range: 0 mm to 10 mm). GM-IC-D was associated with zone 2 placement compared to zone 3 (P=0.036). There was no association between GM-IC-D formation and arch type. In atbad cases the true lumen significantly increased after TEVAR (P=0.017) and the false lumen underwent shrinkage (P=0.025). In ctbad patients the false lumen decreased after TEVAR(P=0.036). Conclusions: The CTAG shows favorable conformability and wall in challenging arch pathologies such as TBAD. Less apposition in LZ 2 versus 3 (p=0.03) Keywords: Aneurysm, Dissecting Cardiovascular Diseases Endovascular Procedures ull-text PDF: BischofffM, Blckler D, Med Sci Research 2015,
17 TEVAR Heidelberg (n=487) March 1997 Oct 2016 Total elektiv Notfall Thoracic aortic aneurysm (TAA) (76.3) 19 (23.7) Sept Sept Ruptured TAA (100.0) Thoracoabdominal aneurysm ( (33.5) 163 patients (male 58%, mean age 66 yrs.) Penetrating aortic ulcer (PAU) (49.2) 33 (60.8) Traumatic aortic rupture (100.0) Chronic Typ B dissection (71.4) 13 (28.6) 407 CTAG devices (verage 2.5 / patients) Acute Typ B dissection (28.8) 32 (71.2) Intramural haematoma (IMH) (53.8) 12 (46.2) Mean 2.5 devices p.p. Type A dissection 5 1 (20.0) 4 (80.0) Aortobronchial fistula 7 1 (14.3) 6 (85.7) Ruptured Patch-aneurysm 3 1 (33.3) 2 (66.7) 83 % Arch involvment (Zone 0-3) Patch-aneurysm 7 5 (71.4) 2 (28.6) Anastomotic aneurysm 7 5 (85.7) 2 (14.3)
18 Indications for TEVAR with CTAG Sept Sept Indication N Acute type B-Dissection 35 PAU 27 TAA* 19 TAAA 18 IMH 17 Traumatic rupture 10 CEAD** 10 rtaa 7 ABF 5 Anastomotic 5 Aneurysm Acute Type A Dissection 3 Posttraumatic TAA 2 Patchaneurysm 2 Patchrupture 1 Corpus alienum 1 (Palakossporn) Symptomatic Aortic Thrombus 1
19 Heidelberg Single Center 6 yr Experience 30 day Results: Technical success 97,5 % Mortality 3.3% Follow up Results: Reintervention rate 21 % Overall mortality (43/166) 26 % Aortic related mortality 8/166) 5 %
20 Advantages - Personal Opinion Oversizing windows for each pathology Unsheated device very flexible for arch and tortous anatomy easy access for multiple devices Highly confomable in the arch Fast or slow deployment 1 Jordan, JVS 2015, 2 Böckler EJVES 2016, 3 Bischoff Med Sci Research 2015, 3 Böckler,Endovascular Today 2014
21 Example of Complex Arch Morphology
22 Future Refinements of the CTAG Branched technology Steering delivery system to enhance control and vessel wall Partial deployment Partial deployment All products are under development and not available or approved for sale in any market.
23 Conclusions Concept is proven in the long run Modifications of CTAG increased conformability CTAG shows very favorable results at mean 2 years No device failures, low major device events CTAG is our prefered device for aortic arch pathologies Continued FU over the next 5 yrs. will be important
24 Going the distance: Conformable Gore TAG device demonstrates durable outcomes over the long D.Böckler University Hospital Heidelberg, Germany
European Experience with a New Thoracic Device. D.Böckler University Hospital Heidelberg Germany
European Experience with a New Thoracic Device D.Böckler University Hospital Heidelberg Germany Disclosures Speaker name: Dittmar Böckler I have the following potential conflicts of interest to report:
Is a Paradigm Shift towards Early Endovascular Treatment of Type B Dissection justified?
Is a Paradigm Shift towards Early Endovascular Treatment of Type B Dissection justified? Dittmar Böckler Department of Vascular and Endovascular Surgery University of Heidelberg, Germany Disclosure Speaker
Performance of the conformable GORE TAG device in Type B aortic dissection from the GORE GREAT real world registry
University of Milan Thoracic Aortic Research Center Performance of the conformable GORE TAG device in Type B aortic dissection from the GORE GREAT real world registry Santi Trimarchi, MD, PhD Associate
Management of intramural hematoma and penetrating ulcers - what is different? D.Böckler University Hospital Heidelberg, Germany
Management of intramural hematoma and penetrating ulcers - what is different? D.Böckler University Hospital Heidelberg, Germany Disclosure Speaker name: Dittmar Böckler I have the following potential conflicts
Santi Trimarchi, MD, PhD Vascular Surgeon Thoracic Aortic Research Center, Director IRCCS Policlinico San Donato University of Milan
The Gore GREAT Registry: Update about a real life data collection Santi Trimarchi, MD, PhD Vascular Surgeon Thoracic Aortic Research Center, Director IRCCS Policlinico San Donato University of Milan Disclosures
Introducing the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System
Introducing the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System K. Oikonomou Department of Vascular Surgery Regensburg University Disclosures W.L. Gore & Associates Sponsored Presentation
Arch Repair with the Bolton Medical RelayBranch Thoracic Stent-graft system: Multicenter experience
Arch Repair with the Bolton Medical RelayBranch Thoracic Stent-graft system: Multicenter experience Joost van Herwaarden, MD, PhD University Medical Center, Utrecht Disclosure I have the following potential
Role of Gender in TEVAR and EVAR results from the GREAT registry
Role of Gender in TEVAR and EVAR results from the GREAT registry Mauro Gargiulo Vascular Surgery University of Bologna - DIMES Policlinico S.Orsola-Malpighi Bologna, Italy mauro.gargiulo2@unibo.it Disclosure
Type 1a Endoleak in hostile neck anatomies: Endoanchor can fix it! D. Böckler University Hospital Heidelberg, Germany
Type 1a Endoleak in hostile neck anatomies: Endoanchor can fix it! D. Böckler University Hospital Heidelberg, Germany Disclosures Speaker name: Dittmar Böckler I have the following potential conflicts
Technique and Outcome of Laser Fenestration For Arch Vessels
Technique and Outcome of Laser Fenestration For Arch Vessels Jean M. Panneton MD, FRCSC, FACS Professor of Surgery Chief & Program Director Division of Vascular Surgery Eastern Virginia Medical School
Treatment of complex thoracic cases Focus on the new Gore Active Control TAG device
Treatment of complex thoracic cases Focus on the new Gore Active Control TAG device Professor Christoph A. Nienaber The Royal Brompton and Harefield NHS Trust Cardiology and Aortic Centre C.Nienaber@rbht.nhs.uk
Predictors of abdominal aortic aneurysm sac enlargement after EVAR Longterm results from the ENGAGE Registry
Predictors of abdominal aortic aneurysm sac enlargement after EVAR Longterm results from the ENGAGE Registry D. Böckler Department of Vascular and Endovascular Surgery University Hospital Heidelberg Disclosure
Challenges with Complex Anatomies Advancing Care in Endovascular Aortic Treatment
Challenges with Complex Anatomies Advancing Care in Endovascular Aortic Treatment Robert Y. Rhee, MD Chief, Vascular and Endovascular Surgery Director, Aortic Center Maimonides Medical Center Brooklyn,
Indications for use. Contraindications within the United States
Indications for use Indications within the United States The GORE TAG Thoracic Endoprosthesis is intended for endovascular repair of all lesions of the descending thoracic aorta, including: Isolated lesions
THE THE MORE MORE NATURAL APPROACH TO OPTIMAL FIT
THE THE MORE MORE NATURAL APPROACH Natural Approach TO Optimal Fit TO OPTIMAL FIT Conformability without Compromise THE STANDARD IN Conformability AND Designed for flexibility and conformability in tortuous
GORE TAG Thoracic Endoprosthesis ANNUAL CLINICAL UPDATE SEPTEMBER 2018 Abstract. Section I GORE TAG Device Clinical experience. Section II Conformable
GORE TAG Thoracic Endoprosthesis ANNUAL CLINICAL UPDATE SEPTEMBER 08 Abstract This annual clinical update provides a review of the ongoing experience with the GORE TAG Thoracic Endoprosthesis There have
How to achieve a successful proximal sealing in TEVAR? Pr L Canaud
How to achieve a successful proximal sealing in TEVAR? Pr L Canaud CHU de Montpellier France Disclosure I have the following potential conflicts of interest to report: Consulting: Medtronic. Proximal neck
RETROGRADE BRANCH. Gustavo S. Oderich MD Professor of Surgery Director of Endovascular Therapy Division of Vascular and Endovascular Surgery
RETROGRADE BRANCH Gustavo S. Oderich MD Professor of Surgery Director of Endovascular Therapy Division of Vascular and Endovascular Surgery FACULTY DISCLOSURE Consulting* Cook Medical Inc., WL Gore Research
ADSORB trial results: Is it enough to switch the paradigm?
ADSORB trial results: Is it enough to switch the paradigm? Jan Brunkwall, MD, PhD Professor and Chairman Complications to acute type B dissection Mortality Rupture Organ Ischemia Dilatation/Aneurysm Refractory
Early Clinical Results with the Valiant Mona LSA Branch Stent-Graft
Early Clinical Results with the Valiant Mona LSA Branch Stent-Graft Frank R. Arko III, MD Professor of Cardiovascular Surgery Director, Endovascular Surgery Co-Director, Aortic Institute Carolinas Medical
Management of Acute Aortic Syndromes. M. Grabenwoger, MD Dept. of Cardiovascular Surgery Hospital Hietzing, Vienna, Austria
Management of Acute Aortic Syndromes M. Grabenwoger, MD Dept. of Cardiovascular Surgery Hospital Hietzing, Vienna, Austria I have nothing to disclose. Acute Aortic Syndromes Acute Aortic Dissection Type
Endoanchor-assisted TEVAR
Endoanchor-assisted TEVAR May 29, 2015 NCVH2015 Grayson H. Wheatley III, MD Director of Aortic and Endovascular Surgery Associate Professor of Surgery Temple University School of Medicine Disclosures Consultant
Abdominal and thoracic aneurysm repair
Abdominal and thoracic aneurysm repair William A. Gray MD Director, Endovascular Intervention Cardiovascular Research Foundation Columbia University Medical Center Abdominal Aortic Aneurysm Endografts
Treatment options of late failures of EVAS. Michel Reijnen Rijnstate Arnhem The Netherlands
Treatment options of late failures of EVAS Michel Reijnen Rijnstate Arnhem The Netherlands Disclosure Speaker name: Michel Reijnen I have the following potential conflicts of interest to report: Consulting
Clinical experience with a new thoracic stent graft system (Ankura TM ). Procedural analysis, 30 days and 6-month results in a single center study
Clinical experience with a new thoracic stent graft system (Ankura TM ). Procedural analysis, 30 days and 6-month results in a single center study Theodoros Kratimenos, MD Consultant, Interventional Radiologist
UC SF. Disclosures. Thoracic Endovascular Aortic Repair 4/24/2009. Management of Acute Dissections: Is There Still a Role for Open Surgery?
UC SF Management of Acute Dissections: Is There Still a Role for Open Surgery? Darren B. Schneider, M.D. Assistant Professor of Surgery and Radiology Division of Vascular Surgery University of California
Understanding the Predictors of Aneurysmal Degeneration in Type B Dissection
Understanding the Predictors of Aneurysmal Degeneration in Type B Dissection A case example illustrating when early endovascular intervention may provide the best outcome. BY DITTMAR BÖCKLER, MD, PhD;
La sindrome aortica acuta oggi
University of Milan Thoracic Aortic Research Center La sindrome aortica acuta oggi Santi Trimarchi, MD, PhD Professore Associato di Chirurgia Vascolare, Università degli Studi di Milano Direttore, Divisione
Mid-term results from ANCHOR: How does this data influence the treatment algorithm for hostile EVAR anatomies
Mid-term results from ANCHOR: How does this data influence the treatment algorithm for hostile EVAR anatomies Jean-Paul P.M. de Vries Head Department of Surgery, University Medical Centre Groningen The
Standardization of the CHEVAR procedure: How a standard approach has improved outcomes. Prof Peter Holt St George s, London
Standardization of the CHEVAR procedure: How a standard approach has improved outcomes Prof Peter Holt St George s, London Disclosure Speaker name: Prof Peter Holt I have the following potential conflicts
My personal experience with INCRAFT in standard and challenging cases
My personal experience with INCRAFT in standard and challenging cases G Pratesi, MD Vascular Surgery University of Rome Tor Vergata giovanni.pratesi@uniroma2.it Disclosure Speaker name: Giovanni Pratesi,
Neurological Complications of TEVAR. Frank J Criado, MD. Union Memorial-MedStar Health Baltimore, MD USA
ISES Online Neurological Complications of Frank J Criado, MD TEVAR Union Memorial-MedStar Health Baltimore, MD USA frank.criado@medstar.net Paraplegia Incidence is 0-4% after surgical Rx of TAAs confined
Optimal Treatment of Chronic Dissection
Optimal Treatment of Chronic Dissection Chun-Che Shih 施俊哲 MD, Ph.D. Chief, Professor Institute of Clinical Medicine National Yang Ming University Division of Cardiovascular Surgery Taipei Veterans General
The Petticoat Technique Managing Type B Dissection with both Early and Long Term Considerations
The Petticoat Technique Managing Type B Dissection with both Early and Long Term Considerations Joseph V. Lombardi, MD Professor & Chief, Division of Vascular & Endovascular Surgery Department of Surgery,
Thoracic Endovascular Aortic Repair (TEVAR) Indications and Basic Procedure
Thoracic Endovascular Aortic Repair (TEVAR) Indications and Basic Procedure Tilo Kölbel, MD, PhD University Heart Center Hamburg University Hospital Eppendorf Disclosure Speaker name: Tilo Kölbel, MD I
Development of a Branched LSA Endograft & Ascending Aorta Endograft
Development of a Branched LSA Endograft & Ascending Aorta Endograft Frank R. Arko III, MD Sanger Heart & Vascular Institute Carolinas Medical Center Charlotte, North Carolina, USA Disclosures Proximal
Life after EVAR 1? The value of open repair for some patients reappears. D. Böckler University Hospital Heidelberg, Germany
Life after EVAR 1? The value of open repair for some patients reappears D. Böckler University Hospital Heidelberg, Germany Disclosure Speaker name: Dittmar Böckler I have the following potential conflicts
Jean M Panneton, MD Professor of Surgery Program Director Vascular Surgery Chief EVMS. Arch Pathology: The Endovascular Era is here
Jean M Panneton, MD Professor of Surgery Program Director Vascular Surgery Chief EVMS Arch Pathology: The Endovascular Era is here Disclosures Consultant: Cook Medical, Bolton Medical, Medtronic Inc, Volcano,
Percutaneous Approaches to Aortic Disease in 2018
Percutaneous Approaches to Aortic Disease in 2018 Wendy Tsang, MD, SM Assistant Professor, University of Toronto Toronto General Hospital, University Health Network Case 78 year old F Lower CP and upper
Combined Endovascular and Surgical Repair of Thoracoabdominal Aortic Pathology: Hybrid TEVAR
Combined Endovascular and Surgical Repair of Thoracoabdominal Aortic Pathology: Hybrid TEVAR William J. Quinones-Baldrich MD Professor of Surgery Director UCLA Aortic Center UCLA Medical Center Los Angeles,
The Auckland Experience with the Nellix EVAS System. Andrew Holden, MBChB, FRANZCR
The Auckland Experience with the Nellix EVAS System Andrew Holden, MBChB, FRANZCR Disclosure Speaker name: Associate Professor Andrew Holden I have the following potential conflicts of interest to report:
Challenges. 1. Sizing. 2. Proximal landing zone 3. Distal landing zone 4. Access vessels 5. Spinal cord ischemia 6. Endoleak
Disclosure I have the following potential conflicts of interest to report: Consulting: Medtronic, Gore Employment in industry Stockholder of a healthcare company Owner of a healthcare company Other(s)
Re-interventions after TEVAR:
Re-interventions after TEVAR: How often does it occur and what are procedures most commonly utilized to treat these issues? Pacific Northwest Endovascular Conference Seattle, WA June 15, 2018 PENN Surgery
GORE EXCLUDER AAA Endoprosthesis demonstrates long-term durability. Michel Reijnen Rijnstate Hospital Arnhem, The Netherlands
GORE EXCLUDER AAA Endoprosthesis demonstrates long-term durability Michel Reijnen Rijnstate Hospital Arnhem, The Netherlands Disclosure Speaker name: Michel Reijnen I have the following potential conflicts
Pioneering EVAR techniques in aortic dissection
Pioneering EVAR techniques in aortic dissection Jianing Yue, Weiguo Fu Department of Vascular Surgery Zhongshan Hospital Fudan University Shanghai, China LINC Asia-Pacific 2016 March 8-10, 2016 Hong Kong
Clinical Trials of Acute and Chronic Dissections. Gregory Landry MD
Clinical Trials of Acute and Chronic Dissections Gregory Landry MD No disclosures Acute vs chronic dissection: Definitions 1950s: Acute < 2 weeks, Chronic > 2 weeks 2013: European Interdisciplinary Consensus
The Role of Stent-Grafts in Marfan Syndrome
The Role of Stent-Grafts in Marfan Syndrome James H. Black, III, MD, FACS The David Goldfarb, MD, Associate Professor of Surgery Chief, Division of Vascular Surgery and Endovascular Therapy The Johns Hopkins
Global Evidence for the Treatment of Type B Aortic Dissection
Global Evidence for the Treatment of Type B Aortic Dissection Ross Milner, MD Professor of Surgery Director, Center for Aortic Diseases September 17, 2016 Disclosures Consultant Cook, Endospan, Medtronic,
Three year experience with multilayer stent in the treatment of thoracoabdominal aneurysms no evidence for aneurysm stabilization
Three year experience with multilayer stent in the treatment of thoracoabdominal aneurysms no evidence for aneurysm stabilization Thomas Larzon, MD, PhD Head of Vascular Surgery Dept of Cardiothoracic
OPEN REOPERATIONS FOR COMPLICATIONS OF ENDOVASCULAR AORTIC PROCEDURES: TIP OF THE ICEBERG?
OPEN REOPERATIONS FOR COMPLICATIONS OF ENDOVASCULAR AORTIC PROCEDURES: TIP OF THE ICEBERG? NICHOLAS T. KOUCHOUKOS, MD DIVISION OF CARDIOVASCULAR AND THORACIC SURGERY MISSOURI BAPTIST MEDICAL CENTER ST.
Treating very short necks ( 4mm <10mm) using the Endurant stent graft + EndoAnchors: 1-year results and current insights
Treating very short necks ( 4mm
Low profile TEVAR: is it an added value? Michel Bosiers, G. Torsello Münster
Low profile TEVAR: is it an added value? Michel Bosiers, G. Torsello Münster Disclosure Speaker name:...michel Bosiers... I have the following potential conflicts of interest to report: Consulting Employment
Objective assessment of current stent grafts: which graft for which lesion. Ludovic Canaud, MD, PhD Pierre Alric, MD, PhD Montpellier, France
Objective assessment of current stent grafts: which graft for which lesion Ludovic Canaud, MD, PhD Pierre Alric, MD, PhD Montpellier, France Conflict of interest: none 1 Introduction Different diseases
Aortic Neck Issues Associated Clinical Sequelae/Implications for Graft Choice
Aortic Neck Issues Associated Clinical Sequelae/Implications for Graft Choice Eric Verhoeven, MD, PhD, A. Katsargyris, MD Department of Vascular and Endovascular Surgery, Paracelsus Medical University,
Access More Patients. Customize Each Seal.
Access More. Customize Each Seal. The Least Invasive Path Towards Proven Patency ULTRA LOW PROFILE TO EASE ADVANCEMENT The flexible, ultra-low 12F ID Ovation ix delivery system enables you to navigate
Conflicts of Interest. When and Why Complex EVAR in Tx of juxta/suprarenal AAA? Summary. Infrarenal EVAR for short necks 2y postop
When and Why Complex EVAR in Tx of juxta/suprarenal AAA? Tim Resch MD Vascular Center Skane University Hospital Conflicts of Interest COOK Medical - Consulting, Speakers Bureau, IP, Research support Medtronic
Ascending Aorta: How I Do It.
Ascending Aorta: Is The Endovascular Approach Realistic? How I Do It. Tilo Kölbel, MD, PhD University Heart Center Hamburg University Hospital Eppendorf Disclosure Speaker name: Tilo Kölbel I have the
When to use standard EVAR with EndoAnchors or CHEVAR in short-neck AAAs LINC ASIA 18
When to use standard EVAR with EndoAnchors or CHEVAR in short-neck AAAs JEAN-PAUL P.M. DE VRIES, DIRECTOR OF VASCULAR SURGERY ST.ANTONIUS HOSPITAL NIEUWEGEIN, THE NETHERLANDS. LINC ASIA-PACIFIC HongKong,
Durable outcomes. Proven performance.
Durable outcomes. Proven performance. GORE EXCLUDER AAA Endoprosthesis GORE EXCLUDER Iliac Branch Endoprosthesis GORE EXCLUDER AAA Endoprosthesis The most-studied* EVAR stent graft designed for durable
Insights from the PROTAGORAS/PERICLES Registries: impact on ChEVAR results
Insights from the PROTAGORAS/PERICLES Registries: impact on ChEVAR results Konstantinos P. Donas, Giovanni Torsello Department of Vascular Surgery St. Franziskus Hospital Münster, Germany Disclosure Speaker
Development of Stent Graft. Kato et al. Development of an expandable intra-aortic prothesis for experimental aortic dissection.
Development of Stent Graft Kato et al. Development of an expandable intra-aortic prothesis for experimental aortic dissection. ASAIO J 1993 The New England Journal of Medicine Downloaded from nejm.org
No Neck Is Needed! Treat the Aneurysm Instead! Andrew Holden, MD Associate Professor of Radiology Auckland City Hospital
No Neck Is Needed! Treat the Aneurysm Instead! Andrew Holden, MD Associate Professor of Radiology Auckland City Hospital Disclosures Andrew Holden, MBChB, FRANZCR No financial investment to disclose Investigator
14F OD Ovation Abdominal Stent Graft System
14F OD Ovation Abdominal Stent Graft System 2 Year Results from the European Study Dierk Scheinert, MD Center for Vascular Medicine Angiology and Vascular Surgery Park Hospital Leipzig, Germany Disclosure
UC SF Early Intervention in Type B Dissection: Results From the INSTEAD XL Trial. Acute Type B Dissection. Outline. Disclosures.
Early Intervention in Type B Dissection: Results From the INSTEAD XL Trial None Disclosures Jade S. Hiramoto, MD, MAS April 4, 2014 Outline Background Current treatment Results from INSTEAD trial Results
EVAR Revision Setting - How can Heli-FX EndoAnchors improve the outcomes?
D. Böckler Department of Vascular and Endovascular Surgery University Hospital Heidelberg EVAR Revision Setting - How can Heli-FX EndoAnchors improve the outcomes? Disclosures Speaker name: Dittmar Böckler
Title. Different arch branched devices are available, is morphology the. main criteria of choice? Ciro Ferrer, MD
Different arch branched devices are available, is morphology the Title main criteria of choice? Ciro Ferrer, MD Vascular Surgery Unit Sapienza University of Rome Disclosure Speaker name: Ciro Ferrer Proctoring/speaking
Patient selection in Hostile Necks and how. to prevent endoleaks a word of caution
Patient selection in Hostile Necks and how to prevent endoleaks a word of caution P M Kasprzak, K. Pfister Department of Vascular Surgery Endovascular Surgery University Hospital Regensburg, Germany Conflict
Improving Endograft Durability with EndoAnchors
Improving Endograft Durability with EndoAnchors William D. Jordan, Jr., M.D. John E. Skandalakis Chair in Surgery Professor and Chief Division of Vascular Surgery and Endovascular Therapy Emory University
Influence of patient selection and IFU compliance on outcomes following EVAS
Influence of patient selection and IFU compliance on outcomes following EVAS LUNCH SYMPOSIUM LINC 2017 Jan MM Heyligers, MD, PhD, FEBVS Consultant Vascular Surgeon Elisabeth TweeSteden Hospital Tilburg,
Optimizing Accuracy of Aortic Stent Grafts in Short Necks
Optimizing Accuracy of Aortic Stent Grafts in Short Necks Venkatesh Ramaiah, MD, FACS Medical Director Arizona Heart Hospital Director Peripheral Vascular and Endovascular Research Arizona Heart Institute
DISCLOSURES ISOLATED DTA LESION? TYPE B DISSECTIONS TREATMENT OPTIONS
Endovascular Repair of Aortic Arch Pathologies; What is available/possible in the U.S. in 2018? Kaiser Permanente Endovascular Symposium 6/2/18 Sukgu M Han, MD, MS Assistant Professor of Clinical Surgery
Animesh Rathore, MD 4/21/17. Penetrating atherosclerotic ulcers of aorta
Animesh Rathore, MD 4/21/17 Penetrating atherosclerotic ulcers of aorta Disclosures No financial disclosures Thank You Dr. Panneton for giving this lecture for me. I am stuck at Norfolk with an emergency
Preliminary Data from the Gore EXCLUDER Thoracoabdominal Branch Endoprosthesis Early Feasibility Study
Preliminary Data from the Gore EXCLUDER Thoracoabdominal Branch Endoprosthesis Early Feasibility Study Mark A Farber, MD Professor of Surgery and Radiology Director, UNC Aortic Network University of North
How to Categorize the Infrarenal Neck Properly? I Van Herzeele Dept. Thoracic and Vascular Surgery, Ghent University, Belgium
How to Categorize the Infrarenal Neck Properly? I Van Herzeele Dept. Thoracic and Vascular Surgery, Ghent University, Belgium Disclosure Speaker name: Isabelle Van Herzeele I have the following potential
UC SF An Algorithm to Choose Which Uncomplicated (Asymptomatic) Acute Type B Dissection Patients Should Undergo TEVAR. Disclosures.
An Algorithm to Choose Which Uncomplicated (Asymptomatic) Acute Type B Dissection Patients Should Undergo TEVAR Disclosures Royalties and research grant support from Cook Medical, Inc. Jade S. Hiramoto,
Anatomical applicability of current off-the-shelf branched endografts in thoracoabdominal aortic aneurysms managed by open surgery.
Leipzig Interventional Course Update on clinical trials Tuesday, January 30 th, 2018 Anatomical applicability of current off-the-shelf branched endografts in thoracoabdominal aortic aneurysms managed by
FLEXIBLE, BALOON EXPANDABLE
EARLY RESULTS OF A CLINICAL TRIAL OF FLEXIBLE, BALOON EXPANDABLE COVERED STENT GRAFT IN ILIAC OCCLUSIVE DISEASE Chris LeCroy Coastal Vascular and Interventional Pensacola, Florida Clinical Trial WL GORE
Endo-Bentall: Fact or Fiction?
Endo-Bentall: Fact or Fiction? Eric E. Roselli, MD Chief, Adult Cardiac Surgery Surgical Director, Aorta Center Heart and Vascular Institute, Cleveland Clinic Disclosures Bolton Cook Cryolife Edwards Gore
Endovascular Management of Thoracic Aortic Pathology Stéphan Haulon, J Sobocinski, B Maurel, T Martin-Gonzalez, R Spear, A Hertault, R Azzaoui
Endovascular Management of Thoracic Aortic Pathology Stéphan Haulon, J Sobocinski, B Maurel, T Martin-Gonzalez, R Spear, A Hertault, R Azzaoui Aortic Center, Lille University Hospital, France Disclosures
Mechanisms of and treatment strategies for dsine after TEVAR for acute and chronic type B aortic dissection- insights from EuREC.
Mechanisms of and treatment strategies for dsine after TEVAR for acute and chronic type B aortic dissection- insights from EuREC Martin Czerny Content EuREC Contributors dsine Mechanisms Results Summary
EXPERIENCE AFTER 500 ENDOLUMINAL STENT GRAFTS. DEVICES SPECIFIC OUTCOME AND LESSONS LEARNED.
EXPERIENCE AFTER 500 ENDOLUMINAL STENT GRAFTS. DEVICES SPECIFIC OUTCOME AND LESSONS LEARNED. A/Prof. B. Patrice Mwipatayi MD, MMed (Surg), MClinEd (Melb), FCS, FRACS Department of Vascular Surgery, Royal
Ovation. Sean Lyden, MD Department Chair, Vascular Surgery Cleveland Clinic
Ovation Sean Lyden, MD Department Chair, Vascular Surgery Cleveland Clinic Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement
No Disclosure. Aortic Dissection in Japan. This. The Challenge of Acute and Chronic Type B Aortic Dissections with Endovascular Aortic Repair
No Disclosure The Challenge of Acute and Chronic Type B Aortic Dissections with Endovascular Aortic Repair Toru Kuratani Department of Cardiovascular Surgery Osaka University Graduate School of Medicine,
How to select FEVAR versus EVAR + endoanchors in short-necked AAAs
How to select FEVAR versus EVAR + endoanchors in short-necked AAAs Jean-Paul P.M. de Vries, Richte C.L. Schuurmann St. Antonius Hospital Nieuwegein, The Netherlands 21st Critical Issues Congress Nuernberg,
Ascending Aorta: Is The Endovascular Approach Realistic?
University Heart Center Hamburg GERMAN AORTIC CENTER UHC Ascending Aorta: Is The Endovascular Approach Realistic? Tilo Kölbel, Christian Detter, Yskert v. Kodolitsch, Sebastian Debus University Heart Center
Taming The Aorta. David Minion, MD Program Director, Vascular Surgery University of Kentucky Medical Center Lexington, Kentucky, USA
Taming The Aorta David Minion, MD Program Director, Vascular Surgery University of Kentucky Medical Center Lexington, Kentucky, USA Faculty Disclosure Consulting: Endologix, Cook 1 Objectives Review the
Endovascular Stent Grafts for Disorders of the Thoracic Aorta
Endovascular Stent Grafts for Disorders of the Thoracic Aorta Policy Number: 7.01.86 Last Review: 9/2018 Origination: 5/2006 Next Review: 9/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC)
EndoVascular Aneurysm Sealing (EVAS) with Nellix
1 2 EndoVascular Aneurysm Sealing (EVAS) with Nellix Designed to seal entire aneurysm with contained biostable polymer Non-modular design with complete fixation Expands endovascular patient eligibility
Talent Abdominal Stent Graft
Talent Abdominal with THE Xcelerant Hydro Delivery System Expanding the Indications for EVAR Treat More Patients Short Necks The Talent Abdominal is the only FDA-approved device for proximal aortic neck
Endovascular Repair o Abdominal. Aortic Aneurysms. Cesar E. Mendoza, M.D. Jackson Memorial Hospital Miami, Florida
Endovascular Repair o Abdominal Aortic Aneurysms Cesar E. Mendoza, M.D. Jackson Memorial Hospital Miami, Florida Disclosure Nothing to disclose. 2 Mr. X AAA Mr. X. Is a 70 year old male who presented to
Endovascular treatment of aortic arch using Relay branched stent grafts
Endovascular treatment of aortic arch using Relay branched stent grafts B. Saint-Lèbes Vascular surgery unit Rangueil Universitary hospital Toulouse France Disclosure of Interest Speaker name: SAINT-LEBES
Aortic stents, types, selection, tricks in deployment.
Aortic stents, types, selection, tricks in deployment. Hamdy Soliman.M.D,FSCAI Consultant of Cardiology&Head of Endovascular Unit National Heart Institute Endovascular Treatment of Thoracic Aortic Aneurysms
I have the following financial relationships to disclose:
Novel Approaches to Endovascular Management of Aortic Aneurysms Rodney A White, MD Medical Director, Vascular Services MemorialCare Heart & Vascular Institute Long Beach Memorial Hospital Long Beach, California
Changing Spectrum of Re-Interventions following TEVAR. 31 st Annual Florida Vascular Society. PENN Surgery
Changing Spectrum of Re-Interventions following TEVAR 31 st Annual Florida Vascular Society PENN Surgery No Disclosures Background: Challenges of analyzing TEVAR Outcomes in regard to re-interventions
Thoracic aortic trauma A.T.O.ABDOOL-CARRIM ACADEMIC HEAD VASCULAR SURGERY DEPARTMENT OF SURGERY UNIVERSITY OF WITWATERSRAND
Thoracic aortic trauma A.T.O.ABDOOL-CARRIM ACADEMIC HEAD VASCULAR SURGERY DEPARTMENT OF SURGERY UNIVERSITY OF WITWATERSRAND Thoracic Aortic Trauma In USA and CANADA 7500-8000 die of blunt thoracic aortic
Current State of Thoracic Branch Devices and Ongoing Clinical Trials
Current State of Thoracic Branch Devices and Ongoing Clinical Trials Hiroo Takayama, MD, PhD Associate Professor of Surgery Director of Cardiovascular Institute Co-Director of Aortic Center NY Presbyterian/Columbia
Jean M. Panneton, MD, FRCSC, FACS. Professor of Surgery, Chief & Program Director Division of Vascular Surgery. Norfolk, VA
Jean M. Panneton, MD, FRCSC, FACS Professor of Surgery, Chief & Program Director Division of Vascular Surgery Eastern Virginia Medical School Norfolk, VA The Houston Aortic Symposium Houston TX, February
Hostile Neck During EVAR, The Role Of Endoanchores
Hostile Neck During EVAR, The Role Of Endoanchores Samer Koussayer, MD, FACS, RVT Prof, Al Faisal University Section Head and consultant Vascular & Endovascular Surgery Division King Faisal Specialist
Bilateral use of the Gore IBE device for bilateral CIA aneurysms and a first interim analysis of the prospective Iceberg registry
Bilateral use of the Gore IBE device for bilateral CIA aneurysms and a first interim analysis of the prospective Iceberg registry Michel MPJ Reijnen, MD, PhD Department of Vascular Surgery, Rijnstate Hospital
Reduction in cardiovascular related adverse events following active sac management with Nellix vs. EVAR: Are there biological advantages?
February 1, 2018 Reduction in cardiovascular related adverse events following active sac management with Nellix vs. EVAR: Are there biological advantages? Patrick Berg M.D. Marienhospital Kevelaer Germany